Kailera Therapeutics, Inc.
$16.41
+1.01 (+6.56%)
Price as of Sep 01, 2026 market close
Performance
- 1 Month
- -5.3%
- 3 Months
- -27.4%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Largest decline max drawdown, since Apr 2026
- -40.8%
Own KLRA?
See how KLRA contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.